Articles
Mergers & Acquisitions
New Report Highlights What the Hospital Consolidation Debate Often Overlooks — and Why It Matters for Patients
A new Kaufman Hall report makes the argument that we need a more “comprehensive analysis of hospital M&A transactions — one that considers impacts on all patients served, broadens the focus to impacts beyond pricing, and considers the consequences if an M&A transaction is not permitted to proceed.”
Setting the Record Straight, Cost Management
Setting the Record Straight: Three Ways the Hospital‑blame Narrative Gets it Wrong
A May 4 guest essay published in The New York Times frames hospitals as the leading “culprit” behind rising health care costs. It reduces a complex health care system and a much-needed conversation on affordability to a caricature.
340B Drug Pricing Program, 340B Payment Reductions in the CY2018 Final OPPS Rule
Blog: Key Insights from Today’s Supreme Court Oral Arguments in AHA’s 340B Case
With a few hours to digest this morning’s oral argument in American Hospital Association v. Becerra, I wanted provide a few high-level reactions.
340B Drug Pricing Program, 340B Payment Reductions in the CY2018 Final OPPS Rule
Live Analysis: Supreme Court Hears Oral Arguments in AHA’s 340B Case
The Supreme Court of the United States Nov. 30 will hear oral arguments in a case brought by the AHA and others asking the court to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program, threatening access care for patients.